Potentiating LPK by treatment with the fructose analog 2,5-anhydro-D-mannitol50 greatly attenuates the hyperglycemia of obese diabetic db/db mice (i.e. with an equivalent leptin receptor defect) but not their STZ-treated wild type controls51. This evidence concerns the gene LEPR and Hyperglycemia.